Cervical cancers avoided by HPV immunisation
Menée en Angleterre auprès de 3 cohortes de femmes vaccinées contre le papillomavirus humain (HPV) et menée à l'aide de données 2006-2019 d'un registre des cancers, cette étude analyse l'effet du programme national de vaccination anti-HPV sur l'incidence des lésions cervicales intra-épithéliales de grade 3 (CIN3) et du cancer du col de l'utérus (27 946 cas)
In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem, one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.
The Lancet , commentaire en libre accès, 2020